The population of geriatric population across the world has grown rapidly over the past several decades. Moreover, this growth has witnessed an unprecedented rate in recent times. In 2016, it was approximated that the population of individuals aged 65 years or older was 8.5% or 617 million of the entire world population. Furthermore, it is projected that the figure will witness an increment to 17% i.e. 1.6 billion by the end of 2050. Such rapid growth of geriatric population is anticipated to present a remunerative growth opportunity for the global digital therapeutics market in the coming times. As geriatric population requires constant healthcare and services & software on mobile or remote monitoring enable better care and this has been a major growth driver for the global digital therapeutic industry. Treatment of several conditions namely blood glucose monitoring, diabetes, cardiovascular diseases have gained immense popularity in recent times, which is further anticipated grow in the coming years.
The Digital Therapeutics Market is segmented on the basis of product type, Applications, Technology, and region
Major Applications of Digital Therapeutics Market covered are:
- Obesity Diabetes Central Nervous System (CNS) Disorders
- Cardiovascular Diseases
- Respiratory Diseases
- Medical Adherence
- Smoking Cessation
Smartphones and internet have played a pivot role in growth of digital therapeutics. As healthcare has become costlier digital therapeutics offer cost saving and reduce hospital visits for patients. Mobile applications & consultation offer better way of providing care to patients suffering from chronic diseases. Moreover, in 2017 US FDA approved mobile application to support treatment of substance use disorders (SUD). The mobile application is used with outpatient therapy to treat alcohol, cocaine, marijuana and stimulant SUDs.
No comments:
Post a Comment